Skip to content
10-Q

Quarterly Report

Alkermes plc. ALKS

0001193125-26-206534

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 166.68M sh
Shares Diluted Q1 2026 · Mar 31, 2026 166.2M sh
Shares Diluted Q1 2026 · Mar 31, 2025 168.74M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $27.7M
Capex Q1 2026 · Mar 31, 2026 $4.09M
Capex Q1 2026 · Mar 31, 2025 $10.11M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$165.74M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $98.81M
Long Term Debt Q1 2026 · Mar 31, 2026 $1.48B
Long Term Debt Q1 2026 · Dec 31, 2025 $0
Short Term Debt Q1 2026 · Mar 31, 2026 $26.5M
Short Term Debt Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2026 $351.55M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $388.57M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.75B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.82B
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.51B
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.46B
Current Liabilities Q1 2026 · Mar 31, 2026 $599.5M
Current Liabilities Q1 2026 · Dec 31, 2025 $543.44M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.51B
Total Liabilities Q1 2026 · Dec 31, 2025 $667.7M
Current Assets Q1 2026 · Mar 31, 2026 $1.36B
Current Assets Q1 2026 · Dec 31, 2025 $1.93B
Total Assets Q1 2026 · Mar 31, 2026 $4.26B
Total Assets Q1 2026 · Dec 31, 2025 $2.49B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.40
Eps Diluted Q1 2026 · Mar 31, 2025 $0.13
Eps Basic Q1 2026 · Mar 31, 2026 −$0.40
Eps Basic Q1 2026 · Mar 31, 2025 $0.14
Sga Expense Q1 2026 · Mar 31, 2026 $264.59M
Sga Expense Q1 2026 · Mar 31, 2025 $171.7M
Rd Expense Q1 2026 · Mar 31, 2026 $103.35M
Rd Expense Q1 2026 · Mar 31, 2025 $71.82M
Net Income Q1 2026 · Mar 31, 2026 −$66.48M
Net Income Q1 2026 · Mar 31, 2025 $22.46M
Operating Income Q1 2026 · Mar 31, 2026 −$48.28M
Operating Income Q1 2026 · Mar 31, 2025 $13.79M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $61.58M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $49.2M
Revenue Q1 2026 · Mar 31, 2026 $392.91M
Revenue Q1 2026 · Mar 31, 2025 $306.51M